chansin
2021-10-27

Lead BET Inhibitor, VYN201, Significantly Reduces Expression of Several Key Pro-Inflammatory Cytokines in Preclinical Studies

VYNE Therapeutics Inc.

Tue, October 26, 2021, 8:00 PM · 8 min read

In this article:

免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白
发表看法